loadpatents
name:-0.036327123641968
name:-0.015944957733154
name:-0.0062918663024902
TESAR; Michael Patent Filings

TESAR; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for TESAR; Michael.The latest application filed is for "generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38".

Company Profile
6.17.30
  • TESAR; Michael - FREIDBERG DE
  • Tesar; Michael - Heidelberg DE
  • Tesar; Michael - Friedberg DE
  • Tesar; Michael - Augsberg DE
  • Tesar; Michael - Weilheim i. Ob. N/A DE
  • Tesar; Michael - Weilheim DE
  • Tesar; Michael - Planegg-Martinsried DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
GENERATION AND PROFILING OF FULLY HUMAN HuCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38
App 20210292431 - TESAR; Michael ;   et al.
2021-09-23
Uses Of Nk Cell Engaging Antibody Fusion Constructs For Treatments
App 20210253698 - Tesar; Michael ;   et al.
2021-08-19
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38
Grant 11,059,902 - Tesar , et al. July 13, 2
2021-07-13
NK cell engaging antibody fusion constructs
Grant 11,001,633 - Tesar , et al. May 11, 2
2021-05-11
Bispecific Egfr/cd16 Antigen-binding Protein
App 20200405833 - Kluge; Michael ;   et al.
2020-12-31
4-1BB binding molecules
Grant 10,640,568 - Ahrens , et al.
2020-05-05
Nk Cell Engaging Antibody Fusion Constructs
App 20200109202 - Tesar; Michael ;   et al.
2020-04-09
GENERATION AND PROFILING OF FULLY HUMAN HuCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38
App 20190077877 - TESAR; MICHAEL ;   et al.
2019-03-14
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38
Grant 10,184,005 - Tesar , et al. Ja
2019-01-22
Anti-cd38 Human Antibodies And Uses Therefor
App 20180215832 - TESAR; MICHAEL ;   et al.
2018-08-02
4-1bb Binding Molecules
App 20180194851 - AHRENS; Bianca ;   et al.
2018-07-12
Novel Humanized Adam17 Antibody
App 20180057601 - LOWE; Peter ;   et al.
2018-03-01
Anti-staphylococcal antibodies
Grant 9,873,733 - Ernst , et al. January 23, 2
2018-01-23
Anti-CD38 human antibodies and uses thereof
Grant 9,758,590 - Tesar , et al. September 12, 2
2017-09-12
4-1bb Binding Molecules
App 20160369000 - Ahrens; Bianca ;   et al.
2016-12-22
Method of producing 4-1BB binding molecules and associated nucleic acids
Grant 9,468,678 - Ahrens , et al. October 18, 2
2016-10-18
Anti-cd38 Human Antibodies And Uses Thereof
App 20160200828 - Tesar; Michael ;   et al.
2016-07-14
Anti-cd38 Human Antibodies And Uses Thereof
App 20160115243 - Tesar; Michael ;   et al.
2016-04-28
Anti-cd38 Human Antibodies And Uses Thereof
App 20160096901 - Tesar; Michael ;   et al.
2016-04-07
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38
App 20160075796 - Tesar; Michael ;   et al.
2016-03-17
Anti-staphylococcal Antibodies
App 20150368323 - ERNST; Christoph Michael ;   et al.
2015-12-24
Generation and profiling of fully human HuCAL gold.RTM.-derived therapeutic antibodies specific for human CD3i
Grant 9,200,061 - Tesar , et al. December 1, 2
2015-12-01
Fully human therapeutic antibodies specific for human CD38
Grant 9,193,799 - Tesar , et al. November 24, 2
2015-11-24
Anti-cd38 Human Antibodies And Uses Therefor
App 20150232571 - Tesar; Michael ;   et al.
2015-08-20
4-1bb Binding Molecules
App 20140377255 - Ahrens; Bianca ;   et al.
2014-12-25
4-1BB binding molecules
Grant 8,821,867 - Ahrens , et al. September 2, 2
2014-09-02
Fully Human Therapeutic Antibodies Specific For Human Cd38
App 20130273072 - Tesar; Michael ;   et al.
2013-10-17
Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38
Grant 8,486,394 - Tesar , et al. July 16, 2
2013-07-16
4-1bb Binding Molecules
App 20130078240 - AHRENS; Bianca ;   et al.
2013-03-28
4-1BB binding molecules
Grant 8,337,850 - Ahrens , et al. December 25, 2
2012-12-25
4-1bb Binding Molecules
App 20120237498 - AHRENS; Bianca ;   et al.
2012-09-20
Anti-CD38 human antibodies and uses thereof
Grant 8,263,746 - Tesar , et al. September 11, 2
2012-09-11
Anti-cd38 Human Antibodies And Uses Thereof
App 20120189622 - Tesar; Michael ;   et al.
2012-07-26
Generation And Profiling Of Fully Human Hucal Gold.rtm.-derived Therapeutic Antibodies Specific For Human Cd38
App 20120076782 - Tesar; Michael ;   et al.
2012-03-29
Generation And Profiling Of Fully Human Hucal Gold-derived Therapeutic Antibodies Specific For Human Cd38
App 20120052078 - Tesar; Michael ;   et al.
2012-03-01
Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38
Grant 8,088,896 - Tesar , et al. January 3, 2
2012-01-03
Anti-CD38 human antibodies and uses thereof
App 20110268726 - Tesar; Michael ;   et al.
2011-11-03
Osteopontin Antibodies
App 20110165170 - Haubrich; Trisha Ann ;   et al.
2011-07-07
Anti-CD38 human antibodies and uses thereof
App 20100285004 - Tesar; Michael ;   et al.
2010-11-11
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
App 20090325290 - Nagy; Zoltan ;   et al.
2009-12-31
Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38
App 20090252733 - Tesar; Michael
2009-10-08
Generation And Profiling Of Fully Human Hucal Gold.RTM.-Derived Therapeutic Antibodies Specific For Human CD38
App 20090123950 - Tesar; Michael
2009-05-14
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
Grant 7,521,047 - Nagy , et al. April 21, 2
2009-04-21
Immunomodulatory human mhc class II antigens-binding polypeptides
App 20040019187 - Nagy, Zoltan ;   et al.
2004-01-29
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
App 20030032782 - Nagy, Zoltan ;   et al.
2003-02-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed